¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
ÇÙÀÇÇÐ Àåºñ ½ÃÀå ¼ºÀå°ú µ¿Çâ:
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é ¼¼°è ÇÙÀÇÇÐ Àåºñ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 84¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 3.1%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÇÙÀÇÇÐÀº Áúº´À» Áø´ÜÇϰí Ä¡·áÇϱâ À§ÇØ ¹æ»ç¼±À» ÀÌ¿ëÇÕ´Ï´Ù. ¶ÇÇÑ Æ¯Á¤ Àå±â°¡ Á¤»óÀûÀ¸·Î ÀÛµ¿ÇÏ´ÂÁö ¿©ºÎ¸¦ ÆÇ´ÜÇÏ´Â °Íµµ Æ÷ÇԵ˴ϴÙ. Áö³ 20³â µ¿¾È ÇÙÀÇÇÐÀÇ ±Þ¼ÓÇÑ ±â¼ú ¹ßÀüÀº ÀÇ·á ÇàÀ§¸¦ ¿ÏÀüÈ÷ º¯È½ÃÄ×½À´Ï´Ù.
¸¸¼º ÁúȯÀÇ Á¶±â Áø´ÜÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ Àü ¼¼°èÀûÀ¸·Î Áø´Ü¿ë ÇÙÀÇÇÐ °Ë»ç°¡ ´«¿¡ ¶ç°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â Àü ¼¼°è Àα¸ÀÇ ¾à 26%¸¦ Â÷ÁöÇÏ´Â ½ÅÈï±¹ÀÇ Åë°è¿¡¼ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌµé ±¹°¡¿¡¼´Â ¿¬°£ 1.9%ÀÇ ºñÀ²·Î Áø´Ü ÇÙÀÇÇÐ °Ë»ç°¡ ½ÃÇàµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹°ú °°Àº ¼±Áø±¹¿¡¼´Â ÇÙÀÇÇÐ °Ë»ç ºóµµ°¡ ¿¬°£ ¾à 2,000¸¸ °Ç¿¡ ´ÞÇÕ´Ï´Ù. Áø´Ü¿¡¼ ÇÙÀÇÇÐ ¹× ¹æ»ç¼ºÀǾàǰÀ» Æ÷ÇÔÇÑ ½Ã¼úÀÇ »ç¿ë ºóµµ°¡ ¸Å³â 10% ÀÌ»ó Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Àü ¼¼°èÀûÀ¸·Î ÇÙÀÇÇÐ ÀåºñÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. ±×·¯³ª ÇÙÀÇÇÐ Àåºñ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ¹æ»ç¼± ÀÇÇп¡ ´ëÇÑ ºÒÃæºÐÇÑ »óȯ Áö¿øÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ºñ¿ë Àý°¨À» À§ÇØ Àç»ý ½Ã½ºÅÛÀ» ±¸¸ÅÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ±âÁ¸ ½ÃÀå ±â¾÷ÀÇ Àåºñ ÆÇ¸Å¿¡ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÇÙÀÇÇÐ Àåºñ ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- ºÏ¹Ì ½ÃÀåÀº ¸¸¼ºÁúȯ Áø´ÜÀ» À§ÇÑ SPECT ¹× PET ½ºÄµ¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼ À¯¸®ÇÑ ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- ºÏ¹Ì¿¡¼ ¹æ»ç¼ºÀǾàǰ »ç¿ë¿¡ ´ëÇÑ Àνİú Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê°¡ Áõ°¡ÇÔ¿¡ µû¶ó »ç¿ë·üÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2016³â 12¿ù FDA´Â ¹Ì±¹ ³» ÀÎü¿ë ¹æ»ç¼ºÀǾàǰÀÇ ¹èÇÕ ¹× ÀçÆ÷Àå¿¡ ´ëÇÑ FDAÀÇ Á¤Ã¥¾ÈÀ» ½ÃÇàÇϱâ À§ÇÑ »õ·Î¿î °¡À̵å¶óÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù.
- 2023³â ½ÃÀå ¼¼ºÐÈ¿¡¼ Á¾¾çÇÐÀº Àü ¼¼°è ¾Ï ¹ßº´·ü°ú À¯º´·ü Áõ°¡·Î ÀÎÇØ ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®¿¡¼ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº ÇÙÀÇÇÐ ÀÌ¿ëÀÌ ºü¸£°Ô Áõ°¡Çϰí ÀÖ´Â ÀϺ», Áß±¹, Àεµ¿¡¼ Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¾Ï°ú ½ÉÇ÷°üÁúȯÀÇ ¹ß»ý·ü¿¡ ´ëÀÀÇϱâ À§ÇØ ¹æ»ç¼± ¸é¿ª¿ä¹ý¿¡ ±â¹ÝÇÑ Ç¥Àû ¾Ï Ä¡·áÀÇ »ç¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
- ÁÖ¿ä ¾÷üµéÀº ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ´Þ¼ºÇϱâ À§ÇØ ½ÅÈï °æÁ¦±¹ÀÇ È®Àå ¹× º¸±Þ ±âȸ¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¼¼°èÀÇ ÇÙÀÇÇÐ Àåºñ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå ¼Ò°³/°èÅë Àü¸Á
- ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ¼¼°èÀÇ ÇÙÀÇÇÐ Àåºñ ½ÃÀå ºÐ¼® Åø
Á¦4Àå ¼¼°èÀÇ ÇÙÀÇÇÐ Àåºñ ½ÃÀå : À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ÇÙÀÇÇÐ Àåºñ ½ÃÀå : À¯Çü º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
- SPECT
- PET
- Æò¸é ½ÅƼ±×·¡ÇÇ ½Ã½ºÅÛ
Á¦5Àå ¼¼°èÀÇ ÇÙÀÇÇÐ Àåºñ ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ÇÙÀÇÇÐ Àåºñ ½ÃÀå : ¿ëµµ º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
- Á¾¾çÇÐ
- ½ÉÀ庴ÇÐ
- ½Å°æÇÐ
- ÀϹÝÀûÀÎ ¿µ»ó
Á¦6Àå ¼¼°èÀÇ ÇÙÀÇÇÐ Àåºñ ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- ÇÙÀÇÇÐ Àåºñ ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
- º´¿ø
- ¿µ»ó Áø´Ü ¼¾ÅÍ
- ±âŸ ¿ëµµ
Á¦7Àå ¼¼°èÀÇ ÇÙÀÇÇÐ Àåºñ ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
- ÇÙÀÇÇÐ Àåºñ ½ÃÀå Á¡À¯À², Áö¿ªº°, 2023³â ¹× 2030³â, 10¾ï ´Þ·¯
- ºÏ¹Ì
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- Äí¿þÀÌÆ®
Á¦8Àå °æÀï »óȲ
- ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
- ±â¾÷ ºÐ·ù
- ±â¾÷ È÷Æ®¸Ê ºÐ¼®
- ±â¾÷ °³¿ä
- GE HealthCare
- Siemens Healthineers AG
- Koninklijke Philips NV
- CANON MEDICAL SYSTEMS CORPORATION
- TTG IMAGING SOLUTIONS
- Mediso Ltd.
- CMR Naviscan
- Neusoft Corporation.
- Shenzhen Anke High-tech Co., Ltd.
- Bracco Imaging SpA
- Biosensors International Group, Ltd.
ksm 24.11.01
Nuclear Medicine Equipment Market Growth & Trends:
The global nuclear medicine equipment market size is expected to reach a value of USD 8.47 billion by 2030 and is projected to grow at a CAGR of 3.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Nuclear medicine involves the utilization of radiation to diagnose diseases or treat them. It also involves determining whether specific organs are functioning normally. Over a stretch of the last two decades, rapid technological advancements in nuclear medicine have transformed the medicine practice.
With growing awareness about the importance of early diagnosis of chronic diseases, there has been a noticeable increase in diagnostic nuclear medicine procedures worldwide. This is evident from stats generated from developing countries, which represents about 26% of the world population. These countries conduct diagnostic nuclear medicine tests at a rate of 1.9% per year. In addition, in developed countries such as the U.S., the frequency of nuclear medicine procedures ranges to about 20 million per year. It is evident that the frequency of use of nuclear medicine and procedures involving radiopharmaceuticals in diagnosis is growing at over 10% per year, indicating a rise in adoption of nuclear medicine equipment worldwide. However, high cost associated with nuclear medicine equipment and insufficient reimbursement support for radiology is expected to hinder the growth of the market. In addition, a growing trend of purchasing refurbished systems for cost saving is expected to affect equipment sales of existing market players.
Nuclear Medicine Equipment Market Report Highlights:
- The North American market is expected to register lucrative growth owing to increasing preference for SPECT and PET scans for diagnosis of chronic diseases
- Growing awareness and government initiatives pertaining to usage of radiopharmaceuticals in the North American region is expected to boost usage rates. For instance, in December 2016, the FDA issued new guidelines to enforce FDA's proposed policies regarding compounding and repackaging of radiopharmaceuticals for human use in the U.S.
- Oncology accounted for the largest market share in application segment in the year 2023 owing to the increasing incidence and prevalence of cancer worldwid
- Asia Pacific market is expected to witness significant growth owing to Japan, China, and India where use of nuclear medicine is increasing at a fast pace. In addition, the usage of radioimmunotherapy-based targeted cancer treatment to counter incidence of cancer and cardiovascular diseases is aiding in the growth of the market
- The key players are focused on expansion & penetration opportunities in developing and emerging economies to achieve sustainable growth in the market
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Global Nuclear Medicine Equipment Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Global Nuclear Medicine Equipment Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
Chapter 4. Global Nuclear Medicine Equipment Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Nuclear Medicine Equipment Market: Type Movement Analysis, 2023 & 2030 (USD Billion)
- 4.3. SPECT
- 4.3.1. SPECT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. PET
- 4.4.1. PET Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Planar Scintigraphy Systems
- 4.5.1. Planar Scintigraphy Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Global Nuclear Medicine Equipment Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Nuclear Medicine Equipment Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
- 5.3. Oncology
- 5.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Cardiology
- 5.4.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Neurology
- 5.5.1. Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. General Imaging
- 5.6.1. General Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Globe Nuclear Medicine Equipment Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Nuclear Medicine Equipment Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
- 6.3. Hospitals
- 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Diagnostic Imaging Centers
- 6.4.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Other End Use
- 6.5.1. Other End Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Globe Nuclear Medicine Equipment Market: Regional Estimates & Trend Analysis
- 7.1. Nuclear Medicine Equipment Market Share, By Region, 2023 & 2030, USD Billion
- 7.2. North America
- 7.2.1. North America Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. U.S. Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Canada Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Mexico Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. U.K.
- 7.3.2.1. U.K. Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Germany Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. Italy
- 7.3.4.1. Italy Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Spain
- 7.3.5.1. Spain Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Denmark
- 7.3.6.1. Denmark Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Sweden
- 7.3.7.1. Sweden Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Norway
- 7.3.8.1. Norway Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
- 7.4.2.1. China Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Japan Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
- 7.4.4.1. India Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
- 7.4.5.1. South Korea Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Australia
- 7.4.6.1. Australia Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1. Thailand Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Brazil Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
- 7.5.3.1. Argentina Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Saudi Arabia
- 7.6.2.1. Saudi Arabia Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. UAE
- 7.6.3.1. UAE Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. South Africa
- 7.6.4.1. South Africa Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Kuwait Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Heat Map Analysis
- 8.4. Company Profiles
- 8.4.1. GE HealthCare
- 8.4.1.1. Participant's Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Siemens Healthineers AG
- 8.4.2.1. Participant's Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Koninklijke Philips N.V.
- 8.4.3.1. Participant's Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. CANON MEDICAL SYSTEMS CORPORATION
- 8.4.4.1. Participant's Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. TTG IMAGING SOLUTIONS
- 8.4.5.1. Participant's Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Mediso Ltd.
- 8.4.6.1. Participant's Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. CMR Naviscan
- 8.4.7.1. Participant's Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Neusoft Corporation.
- 8.4.8.1. Participant's Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Shenzhen Anke High-tech Co., Ltd.
- 8.4.9.1. Participant's Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.10. Bracco Imaging S.p.A.
- 8.4.10.1. Participant's Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Recent Developments/ Strategic Initiatives
- 8.4.11. Biosensors International Group, Ltd.
- 8.4.11.1. Participant's Overview
- 8.4.11.2. Financial Performance
- 8.4.11.3. Product Benchmarking
- 8.4.11.4. Recent Developments/ Strategic Initiatives